Remove BMI Remove Public Health Remove Research
article thumbnail

Research highlights disparities in heart disease, stroke trends worldwide

Medical Xpress - Cardiology

Incidence of stroke and ischemic heart disease are declining around the world, except for in a handful of regions, according to research in PLOS Global Public Health.

article thumbnail

H-NMR metabolomics identifies three distinct metabolic profiles differentially associated with cardiometabolic risk in patients with obesity in the Di@bet.es cohort

Cardiovascular Diabetology

Obesity is a complex, diverse and multifactorial disease that has become a major public health concern in the last decades. The current classification systems relies on anthropometric measurements, such as BMI.

Obesity 52
article thumbnail

Global Trends in Cardiovascular Diseases: Insights from the 2023 Almanac

Cardiology Update

Major Trends in Global CVD and Risks The 2023 Almanac presents crucial insights into the Global Burden of Disease (GBD) for the period 1990-2022, revealing five major trends in global cardiovascular diseases (CVD) and associated risks, each with profound implications for clinical practice and research. in High-Income Asia Pacific to 432.3

article thumbnail

Smoking Cannabis Associated with Increased Risk of Heart Attack, Stroke

DAIC

a data analyst at Massachusetts General Hospital in Boston and formerly a researcher at the Center for Tobacco Control Research and Education at the University of California, San Francisco , where she conducted the study as part of her postdoctoral work. Cannabis use could be an important, underappreciated source of heart disease.”

article thumbnail

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

DAIC

The estimated relative risk reduction of MACE was 20% vs placebo (HR 0.80 [95% CI: 0.72, 0.90] p 1,2 The reduction of MACE with Wegovy was not impacted by age, sex, race, ethnicity, baseline BMI, or level of renal function impairment. in patients randomized to Wegovy 2.4 mg and 36.4% of patients receiving placebo. 2 What is Wegovy?

Obesity 111
article thumbnail

The global burden of disease attributable to high body mass index in 204 countries and territories from 1990 to 2021 with projections to 2050: An analysis of the Global Burden of Disease Study 2021

European Journal of Heart Failure

Abstract Aims Understanding the global burden of disease attributable to high body mass index (BMI) is essential for informing public health strategies and interventions to mitigate the impact of obesity-related conditions. Globally in 2021, the deaths and DALYs attributable to high BMI have risen 2.54-fold fold and 2.68-fold

BMI 40